Search Results - "Krüse, V."

Peritumoral indoleamine 2,3-dioxygenase expression in melanoma: an early marker of resistance to immune control? by Chevolet, I., Speeckaert, R., Haspeslagh, M., Neyns, B., Krüse, V., Schreuer, M., Van Gele, M., Van Geel, N., Brochez, L.

“…Summary Background Indoleamine 2,3‐dioxygenase (IDO) is an emerging immunomodulating factor in cancer. IDO expression in tumour‐negative sentinel lymph nodes…”
Get full text

Recommendations for skin cancer consultation and surgery during COVID‐19 pandemic by Brochez, L., Baurain, J.F., Del Marmol, V., Nikkels, A., Kruse, V., Sales, F., Stas, M., Van Laethem, A., Garmyn, M.

“…Linked articles: COVID‐19 SPECIAL FORUM. J Eur Acad Dermatol Venereol 2020; 34: e433–e466…”
Get full text

Imaging requirements for personalized medicine: the oncologists point of view by Kruse, V, Belle, S Van, Cocquyt, V

“…While conventional chemotherapy regimens aim to be cytotoxic against proliferating cells, molecular targeted therapies are directed at specific…”
Get more information

NEPHROTOXICITY OF ANTICANCER DRUGS - AN UNDERESTIMATED PROBLEM? by Lameire, N, Kruse, V, Rottey, S

“…Nephrotoxicity is an inherent adverse effect of certain anticancer drugs and may result in a variety of functional consequences that include any combination of…”
Get full text

Reproducibility of FDG PET based metabolic tumor volume measurements and of their FDG distribution within by Kruse, V, Mees, G, Maes, A, D'Asseler, Y, Borms, M, Cocquyt, V, Van De Wiele, C

“…The aim of this study was to report on the reproducibility of F-18-fluorodeoxyglucose (FDG) PET MTV (metabolic tumor volume) 40% and MTV2.5, as well as on the…”
Get full text

Sunitinib for metastatic renal cell cancer patients: observational study highlighting the risk of important drug-drug interactions by Kruse, V., Somers, A., Van Bortel, L., De Both, A., Van Belle, S., Rottey, S.

“…Summary What is known and objective Sunitinib, a CYP3A4 substrate, is standard of care treatment in metastatic renal cell carcinoma (mRCC) and is administered…”
Get full text

Successful strategy to treat a solitary cystic melanoma brain metastasis by Kruse, V., Boterberg, T., Acou, M., Creytens, D., Van den Broecke, C., Brochez, L., Hallaert, G.

Get full text

EURO-VOYAGE: Effectiveness and safety of ipilimumab (IPI) administered during a European Expanded Access Programme (EAP) in patients with advanced melanoma (MEL) by Ascierto, P, Bastholt, L, Mohr, P, Hoeller, C, Robert, C, Larkin, J, Dummer, R, Ekbom, A, Chiarion-Sileni, V, Dutriaux, C, Mortier, L, Neyns, B, Nyakas, M, Garbe, C, Baurain, J.F, Kruse, V, Svane, I.M, Alfaya, L, Ciria, C, Blank, C

Get full text

Covalent binding of molecules to plasma immersion ion implantation‐activated microparticles for delivery into cells by Kruse, Hedi V., Tran, Clara T. H., Zandwijk, Nico, Suchowerska, Natalka, McKenzie, David R., Reid, Glen

“…Delivery of biomolecules to target cells is an essential step in gene therapy, targeted drug delivery, and cell imaging, and can be achieved by encapsulation…”
Get full text

Plasma ion implantation of 3D‐printed PEEK creates optimal host conditions for bone ongrowth and mineralisation by Kruse, Hedi V., McKenzie, David R., Clark, Jonathan R., Suchowerska, Natalka

“…Polyether ether ketone (PEEK) is a three‐dimensional (3D)‐printable material with excellent mechanical properties for bone replacement implants. However,…”
Get full text

CA 15.3 measurements for separating FDG PET/CT positive from negative findings in breast carcinoma recurrence. Factors influencing the area under the ROC curve by Kruse, V, Van de Wiele, C, Borms, M, Maes, A, Pottel, H, Sathekge, M, Cocquyt, V

“…In breast cancer CA 15.3 is considered the tumour marker of choice. CA 15.3 is directly related to the disease extent and to hormone status (estrogen receptor…”
Get more information

Plasma immersion ion‐implanted 3D‐printed PEEK bone implants: In vivo sheep study shows strong osseointegration by Kruse, Hedi V., Lewin, William T., Suchowerska, Natalka, Al Maruf, D. S. Abdullah, Cheng, Kai, Clark, Jonathan R., McKenzie, David R.

“…Adhesion of regenerating bone tissue to orthopaedic implants is critical to their long‐term success. Titanium has excess rigidity, interferes with imaging, and…”
Get full text

Exposure to ultraviolet radiation causes apoptosis in developing sea urchin embryos by Lesser, Michael P, Kruse, Valerie A, Barry, Thomas M

“…Laboratory exposures of embryos from the sea urchin Strongylocentrotus droebachiensis to ultraviolet B radiation (UV-B, 290-320 nm), equivalent to a depth of…”
Get full text

HIGH DOSE CHEMOTHERAPY AND STEM CELL RESCUE FOR METASTATIC GERM CELL TUMOURS: LONG TERM RESULTS FROM A SINGLE INSTITUTION by Kruse, V, Noens, L, Lumen, N, Hoebeke, P, Van Belle, S, Rottey, S

“…Purpose: To evaluate the long term results and the characteristics of patients treated with high dose chemotherapy (HDCT) for an advanced germ cell tumour at…”
Get full text

Seasonal temperature compensation in the horse mussel, Modiolus modiolus: metabolic enzymes, oxidative stress and heat shock proteins by Lesser, Michael P, Kruse, Valerie A

“…Seasonal collections of the subtidal horse mussel, Modiolus modiolus, from a depth of 10 m were made at the Isles of Shoals, New Hampshire to assess changes in…”
Get full text

CN32 University Hospital Ghent Cancer centre nurse-led e-health support in cancer care during the SARS-CoV-2 pandemic: Results of a single centre observation by De Munter, J., Waeytens, I., Kruse, V.

Get full text

A Preclinical Trial Protocol Using an Ovine Model to Assess Scaffold Implant Biomaterials for Repair of Critical-Sized Mandibular Defects by Xin, Hai, Ferguson, Ben M., Wan, Boyang, Al Maruf, D S Abdullah, Lewin, William T., Cheng, Kai, Kruse, Hedi V., Leinkram, David, Parthasarathi, Krishnan, Wise, Innes K., Froggatt, Catriona, Crook, Jeremy M., McKenzie, David R., Li, Qing, Clark, Jonathan R.

“…The present work describes a preclinical trial (in silico, in vivo and in vitro) protocol to assess the biomechanical performance and osteogenic capability of…”
Get full text

1750P Knowledge and awareness of hepatitis B and C virus reactivation among oncologists in Dutch-speaking Belgium: The CHOICe trial (Chronic Hepatitis B/C screening in patients on immunosuppressive therapy and chemotherapy) by Coessens, M., Van de Bruaene, C., Verlinden, W., Geerts, A., Kruse, V., Aerts, M., Bourgeois, S., Colle, I., Maus, J., Orlent, H., Van Overbeke, L., Van Steenkiste, C., Schouten, J.

Get full text

COMBI-rechallenge: a phase II clinical trial on dabrafenib plus trametinib in BRAFV600-mutant melanoma patients who previously experienced progression on BRAF(+MEK)-inhibition by Schreuer, M., Kruse, V., Jansen, Y., Neyns, B.

Get full text

PARP INHIBITORS IN ONCOLOGY: A NEW SYNTHETIC LETHAL APPROACH TO CANCER THERAPY by Kruse, V, Rottey, S, De Backer, O, Van Belle, S, Cocquyt, V, Denys, H

Get full text